Immunotherapy In Chromophobe RCC
Pavlos Msaouel, MD, PhD Assistant Professor Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center discusses Immunotherapy In Chromophobe RCC. At Kidney Cancer Association Na...
Author: kidneycancer
Added: 10/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - October 11, 2018 Category: Cancer & Oncology Source Type: podcasts
Are biomarkers the future in Non-Hodgkin Lymphoma?
Speaking at the 2018 Society of Hematologic Oncology (SOHO) Annual Meeting in Houston, TX, Nathan Fowler, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the increasin...
Author: VJHemOnc
Added: 09/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 19, 2018 Category: Cancer & Oncology Source Type: podcasts
Follicular lymphoma: identifying high-risk patients
Patients that relapse or are resistant to treatments are classified as high-risk in follicular lymphoma. Here, Nathan Fowler, MD, of The University of Texas MD Anderson Cancer Center, Houston, TX, dis...
Author: VJHemOnc
Added: 09/19/2018 (Source: Oncology Tube)
Source: Oncology Tube - September 19, 2018 Category: Cancer & Oncology Source Type: podcasts
Positive results for IL-3R inhibition in BPDCN
Blastic plasmocytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy typically associated with poor patient outcomes. Naveen Pemmaraju, MD, of the University of Texas MD Anderson Ca...
Author: VJHemOnc
Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts
Highlights: ASCO 2018 oral abstract presentations
Speaking from the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL, Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center, Houston, TX, gives an...
Author: VJHemOnc
Added: 07/05/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 5, 2018 Category: Cancer & Oncology Source Type: podcasts
TWiV 500: Keep virology weird
The entire TWiV team visits The University of Texas in Austin to record episode #500 with guests Jinny Suh, Jason McClellan, and Jon Huibregtse. Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, and Kathy Spindler Guests: Jinny Suh, Jason McClellan, and Jon Huibregtse Become a patron of TWiV! Links for this episode A big list of science podcasts Immunize Texas McClellan Lab Huibregtse Lab John Ring LaMontagne Center for Infectious Disease Video of this episode (YouTube) Weekly Science Picks Alan - The Airplane Cabin Microbiome Rich - Coalition for Epidemic Preparedness Innovations (CEPI)(wiki) ...
Source: This Week in Virology - MP3 Edition - July 1, 2018 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Target Tumors More Effectively | Better Combinations, Find Mechanisms of Resistance
Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares Target Tumors More Effectively | Better Combinations, Find Mechanisms of Resistance at ASCO 2018
Author: Annual-Meeting
Added: 06/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2018 Category: Cancer & Oncology Source Type: podcasts
ASCO Helps Impact Ability to Communicate | Helps Understand Knowledge Gaps
Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares ASCO Helps Impact Ability to Communicate | Helps Understand Knowledge Gaps at ASCO 2018
Author: Annual-Meeting
Added: 06/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2018 Category: Cancer & Oncology Source Type: podcasts
Moving Toward Precision Medicine | Field is Growing Quickly & Changes are Coming
Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares Moving Toward Precision Medicine | Field is Growing Quickly & Changes are Coming at ASCO 2018
Author: Annual-Meeting
Added: 06/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2018 Category: Cancer & Oncology Source Type: podcasts
Bladder Cancer is No Longer Just One Disease | Different Biologies & Response in Benefit
Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares Bladder Cancer is No Longer Just One Disease | Different Biologies & Response in Benefit at ASCO 2018<br />
Author: Annual-Meeting
Added: 06/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2018 Category: Cancer & Oncology Source Type: podcasts
Erdafitinib Currently Not FDA-Approved | Granted Breakthrough Designation Therapy
Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares Erdafitinib Currently Not FDA-Approved | Granted Breakthrough Designation Therapy at ASCO 2018
Author: Annual-Meeting
Added: 06/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2018 Category: Cancer & Oncology Source Type: podcasts
Studies for Fibroblast Growth Factors Receptors | Mutations & Trans-Location Fusion Protiens
Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares Studies for Fibroblast Growth Factors Receptors | Mutations & Trans-Location Fusion Proteins at ASCO 2018
Author: Annual-Meeting
Added: 06/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2018 Category: Cancer & Oncology Source Type: podcasts
Therapy for Metastatic Urothelial Carcinoma | Erdafitnib, a Pan-FGFR Inhibitor
Arlene O. Seifker-Radtke, MD, University of Texas MD Anderson Cancer Center shares Therapy for Metastatic Urothelial Carcinoma | Erdafitnib, a Pan-FGFR Inhibitor at ASCO 2018
Author: Annual-Meeting
Added: 06/21/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 21, 2018 Category: Cancer & Oncology Source Type: podcasts
Kidney Cancer Experts at UT Southwestern discuss the CARMENA trial
Dr. Jim Brugarolas, Director of the UT Southwestern Kidney Cancer Program, sat down with expert urologist, Dr. Vitaly Margulis, and leading oncologist, Dr. Hans Hammers, in a roundtable discussion abo...
Author: University of Texas Southwestern Medical Center, Kidney Cancer Program
Added: 06/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - June 11, 2018 Category: Cancer & Oncology Source Type: podcasts
Upcoming results from clinical trials for treating relapsed, low grade lymphoma
Nathan Fowler, MD, from the University of Texas MD Anderson Cancer Center, Houston, TX, talks about the clinical trials with results being released soon for the treatment of low grade lymphoma. Trials...
Author: VJHemOnc
Added: 05/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - May 18, 2018 Category: Cancer & Oncology Source Type: podcasts
